19,566 results match your criteria Extracorporeal Membrane Oxygenation


Recent advances in understanding neuro.

Curr Opin Genet Dev 2022 Jun 27;75:101938. Epub 2022 Jun 27.

Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, USA; Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA. Electronic address:

Congenital heart disease affects around 1% of live births worldwide and can be associated with a wide range of neurodevelopmental disorders. Genetic factors are a major risk factor for poorer neurodevelopmental outcomes. Recent studies have highlighted the complexity of the underlying genetic contributions, including monogenic, oligogenic, and polygenic factors, and their interrelatedness with other risk factors such as preoperative factors (preterm birth, extracardiac malformation, and low birth weight), perioperative factors (anesthesia, type of surgery use of extracorporeal membrane oxygenation, cyanosis, and length of stay in the intensive care unit), postoperative factors (function of the heart after the surgery), and psychosocial factors (socioeconomic status or parent education). Read More

View Article and Full-Text PDF

Clinical outcomes after tracheostomy in patients with coronavirus disease 2019: a single-center experience in Japan.

Surg Today 2022 Jun 30. Epub 2022 Jun 30.

Department of Surgery, National Center for Global Health and Medicine, Tokyo, Japan.

Purpose: Many patients with coronavirus disease 2019 require mechanical ventilation and tracheostomy. However, the timing and indications for tracheostomy are controversial. This study assessed 11 patients with coronavirus disease 2019 who underwent tracheostomy with clinical information and retrospective analyses. Read More

View Article and Full-Text PDF

Aortic valve replacement using On-X valve in a child postorthotopic heart transplantation.

Cardiol Young 2022 Jun 30:1-2. Epub 2022 Jun 30.

Department of Paediatric Cardiology, CHI Crumlin, Dublin 12, Ireland.

A 20-month-old girl presented with severe dilated cardiomyopathy and decompensated congestive cardiac failure. Despite escalating inotropic and mechanical ventilation support, she required placement on extracorporeal membrane oxygenation and transfer to the transplant centre in Newcastle, England. She was placed on biventricular assist device and then Berlin Heart but failed to show any recovery of ventricular function. Read More

View Article and Full-Text PDF

Liver transplantation from a non-heart-beating donor.

Korean J Transplant 2020 Dec 18;34(4):302-307. Epub 2020 Dec 18.

Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Interest in utilizing organs from non-heart-beating donors (NHBDs) has increased because of the organ shortage. However, liver transplantation (LT) from NHBDs has been scarcely performed in Korea because only Maastricht category IV is legally permitted. We present one case of LT from an NHBD with extracorporeal membrane oxygenation (ECMO) support. Read More

View Article and Full-Text PDF
December 2020

Outcomes of Transferred Adult Venovenous and Venoarterial Extracorporeal Membrane Oxygenation Patients: A Single Center Experience.

Front Med (Lausanne) 2022 13;9:913816. Epub 2022 Jun 13.

Department of Extracorporeal Life Support Center, Department of Cardiac Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Objectives: Extracorporeal membrane oxygenation (ECMO) patients with or without transport both have high hospital mortality rate and there are few data on adult VA-ECMO transport patients. Hence, this study was designed to analyze factors that affect the outcomes of patients with ECMO transport.

Methods: This study retrospectively enrolled 126 ECMO patients transferred from regional hospital to the First Affiliated Hospital of Zhengzhou University by our ECMO team during June 2012 to Sept 2020. Read More

View Article and Full-Text PDF

Feasibility Study of a Fully Synchronous Virtual Critical Care Elective Focused on Learner Engagement.

Cureus 2022 May 28;14(5):e25427. Epub 2022 May 28.

Anesthesiology and Critical Care, Johns Hopkins University School of Medicine, Baltimore, USA.

Background: The COVID-19 pandemic disrupted clinical education for medical students. With the rise of variants, meaningful in-person clinical experiences remain threatened. This report describes the design, implementation, and evaluation of a fully synchronous virtual critical care elective for medical students focused on learner engagement. Read More

View Article and Full-Text PDF

Organ donation after controlled circulatory death (Maastricht classification III) following the withdrawal of life-sustaining treatment in Korea: a suggested guideline.

Korean J Transplant 2021 Jun;35(2):71-76

Division of Acute Care Surgery, Department of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.

The "Act on hospice and palliative care and decisions on life-sustaining treatment for patients at the end of life" was enacted in February 2018 in Korea. Therefore, we suggest a Korean guideline for organ donation after circulatory death (DCD) category III after the withdrawal of life-sustaining treatment (WLST). Implementation of WLST includes stopping ventilation, extubation, discontinuation of inotropics and vasoconstrictors, cessation of continuous renal replacement therapy, and cessation of extracorporeal membrane oxygenation. Read More

View Article and Full-Text PDF

Nosocomial Infections During Extracorporeal Membrane Oxygenation in Pediatric Patients: A Multicenter Retrospective Study.

Front Pediatr 2022 13;10:873577. Epub 2022 Jun 13.

Extracorporeal Life Support Center of Cardiovascular Surgery, The Second Xiangya Hospital of Central South University, Central South University, Changsha, China.

Objective: Extracorporeal membrane oxygenation (ECMO) is increasingly used in critically ill patients with respiratory and/or cardiac failure. This study aimed to investigate the epidemiology and risk factors of nosocomial infection (NI) in pediatric patients who underwent ECMO for respiratory and/or circulatory failure.

Methods: Medical records for patients that were administered underwent ECMO support at Xiangya Second Hospital of Central South University, The Sixth Medical Center of PLA General Hospital, and Children's Hospital Affiliation of Zhengzhou University, from September 2012 to December 2019 were retrospectively reviewed. Read More

View Article and Full-Text PDF

The need for standardized echocardiographic work-up prior extracorporeal membrane oxygenation support in cardiogenic shock.

Oxf Med Case Reports 2022 Jun 23;2022(6):omac053. Epub 2022 Jun 23.

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

View Article and Full-Text PDF

Impact of extended-criteria donor lungs according to preoperative recipient status and age in lung transplantation.

Korean J Transplant 2020 Sep;34(3):185-192

Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

Background: Organ donor shortage remains as one of the limiting factors for lung transplantation. Given the increase in waiting time, preoperative condition has worsened and affects surgical outcomes. This study aimed to evaluate the immediate postoperative and long-term outcomes of lung transplantation in extended-criteria donor (ECD) lungs compared with standard-criteria donor (SCD) lungs. Read More

View Article and Full-Text PDF
September 2020

Outcomes of infants with pulmonary atresia with intact ventricular septum listed for heart transplantation: A multi-institutional study.

Pediatr Transplant 2022 Jun 29:e14338. Epub 2022 Jun 29.

Division of Pediatric Cardiology, Nationwide Children's Hospital, Ohio State University, Columbus, Ohio, USA.

Background: Management of infants with pulmonary atresia/intact ventricular septum (PA/IVS) is variable. Because of higher mortality in more severe forms, heart transplant (HT) is an acceptable approach, but waitlist and post-transplant outcomes are unclear. This study compared outcomes of infants with PA/IVS vs. Read More

View Article and Full-Text PDF

[Whether extracorporeal membrane oxygenation can be used in adult patients with sepsis and septic shock?]

Zhonghua Yi Xue Za Zhi 2022 Jul;102(25):1899-1903

Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Sepsis is a critical medical problem that needs to be solved urgently worldwide. Some patients with sepsis have refractory shock or/and severe respiratory failure, which may require supporting with extracorporeal membrane oxygenation (ECMO). Particularly, it is important to choose the optimal mode and grasp the optimal timing of the initiation in the experienced ECMO center. Read More

View Article and Full-Text PDF

[Mechanical ventilation strategy for acute respiratory distress syndrome patients supported by veno-venous extracorporeal membrane oxygenation].

Authors:
L Sang Y M Li

Zhonghua Yi Xue Za Zhi 2022 Jul;102(25):1895-1898

Department of Critical Care Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou 510120, China.

The mortality of acute respiratory distress syndrome (ARDS) patients is very high, veno-venous extracorporeal membrane oxygenation (VV-ECMO) has been proved to improve the prognosis of these patients, but the maximization of this benefit relies on the appropriate mechanical ventilation strategy; with the new research evidence arise, scholars have reached a certain consensus on how to implement mechanical ventilation in ARDS patients supported by VV-ECMO, but there are still many controversies. Based on the evidences of current researches and clinical experiences, this article analyzes the hot issues of mechanical ventilation strategy for these patients, including the implementation of early 'overprotective' ventilation strategy, whether spontaneous breathing allowed, prone ventilation and ventilator weaning. Read More

View Article and Full-Text PDF

[Weaning of veno-venous extracorporeal membrane oxygenation: when to use the "resting lung"].

Authors:
R Wang B Sun

Zhonghua Yi Xue Za Zhi 2022 Jul;102(25):1891-1894

Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.

Differences in weaning strategies for veno-venous extracorporeal membrane oxygenation (VV-ECMO) are based on expert opinions rather than clinical evidence. Therefore, each center has its own "unique skills". The timing of VV-ECMO weaning has not received due attention. Read More

View Article and Full-Text PDF

[Timing of starting veno-venous extracorporeal membrane oxygenation].

Zhonghua Yi Xue Za Zhi 2022 Jul;102(25):1887-1890

Department of Emergency and Critical Care, the Second Hospital of Jilin University, Changchun 130041, China.

Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is mainly used for reversible acute respiratory failure that is difficult to correct with mechanical ventilation and other conventional measures or preparation of lung transplantation. Acute respiratory distress syndrome (ARDS) is a typical clinical syndrome of acute respiratory failure. The timing of starting VV-ECMO in severe ARDS still face many controversies and challenges. Read More

View Article and Full-Text PDF

[Current status and future trends of left ventricular decompression strategies in veno-arterial extracorporeal membrane oxygenation].

Authors:
H Zhao

Zhonghua Yi Xue Za Zhi 2022 Jul;102(25):1882-1886

In-vitro Life Support Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.

Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a great weapon to save patients with acute heart failure. At present, in most cases, VA-ECMO is perfused through femoral artery intubation, and the external blood flow is opposite to the direction of cardiac ejection, which will increase the left ventricular afterload and lead to left ventricular expansion, which is not conducive to the recovery of cardiac function. This paper reviews the development course of left ventricular decompression at home and abroad, summarizes the present situation of left ventricular decompression technology at home and abroad, analysis of left ventricular decompression technology advantages and existing problems, and put forward their own opinions, to analyze the prevention and solution of left ventricular distension in VA-ECMO, may explore better method, improve the success rate of treatment in patients with heart failure. Read More

View Article and Full-Text PDF

[Successful prediction and the process of the weaning of veno-arterial extracorporeal membrane oxygenation].

Authors:
F Li W Lai Y Kang

Zhonghua Yi Xue Za Zhi 2022 Jul;102(25):1878-1881

Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu 610041, China.

The weaning of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is one of the clinical challenges, and hospitals have developed experience-based strategies, so there is still a lack of unified standards and procedures for weaning. This paper discusses this issue from the definition of weaning success, evaluation of patients before weaning, predictive indicators, weaning process, etc. Summarizing research progress and problems so that providing guidance for the development of ECMO in the future, such as perfecting weaning process and putting forward scoring system to predict weaning success and clinical outcome. Read More

View Article and Full-Text PDF

[Initiation timing of veno-arterial extracorporeal membrane oxygenation].

Zhonghua Yi Xue Za Zhi 2022 Jul;102(25):1874-1877

Department of Intensive Care Unit, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu 610072, China.

Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a salvage therapy for critical patients with refractory cardiogenic shock caused by various reasons. It can temporarily replace cardiopulmonary function, and rapidly improve hypoxemia, increase systemic oxygen content and remove carbon dioxide. Although the Extracorporeal Life Support Organization (ELSO) guideline proposed clear indication for VA-ECMO, the heterogeneity of cardiac pathogeny is large, so the clear timing of ECMO initiation is still vague. Read More

View Article and Full-Text PDF

[Current satus and future direction of neuromonitoring in patients on extracorporeal membrane oxygenation].

Authors:
Z W Wang L N Zhang

Zhonghua Yi Xue Za Zhi 2022 Jul;102(25):1870-1873

Department of Critical Care Medicine, Xiangya Hospital, Central South University, National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Hunan Provincial Clinical Research Center for Critical Care Medicine, Changsha 410008, China.

Neurological complications significantly affect the short-and long-term outcomes of patients with extracorporeal membrane oxygenation (ECMO). With the increasing application of ECMO, more and more attention has been paid to the neuromonitoring in ECMO patients. Although many neuromonitoring approaches have already been used clinically, the sensitivity and specificity utilizing one single neuromonitoring assessment to predict brain injury is still insufficient. Read More

View Article and Full-Text PDF

[Current status and challenges of anticoagulation management in extracorporeal membrane oxygenation].

Authors:
X Si X D Guan

Zhonghua Yi Xue Za Zhi 2022 Jul;102(25):1864-1869

Department of Critical Care Medicine, the First Affiliated Hospital of Sun Yat-Sen University, the Emergency and Critical Care linical Research Center of Guangdong province, Guangzhou 510080, China.

The anticoagulant management of extracorporeal membrane oxygenation(ECMO) is facing great challenges. Complications related to the coagulation system such as bleeding or embolism are one of the main factors affecting the mortality of patients. How to control the dynamic balance between thrombosis and bleeding complications has become the top priority of ECMO management. Read More

View Article and Full-Text PDF

[Current situation and problems of extracorporeal membrane oxygenation use in China].

Authors:
X Zhou

Zhonghua Yi Xue Za Zhi 2022 Jul;102(25):1859-1863

Department of Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, China National Critical Care Quality Control Center, ECMO Quality Improvement Action (EQIA) Study Group, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100710, China Information Center Department/Department of Information Management, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100710, China.

Extracorporeal membrane oxygenation (ECMO) technology has experienced from nothing, evolving from high-Tech technology with high mortality to the well-known last life-saving weapon. At present, ECMO technology is booming and widely used in the treatment of patients with severe respiratory failure and cardiogenic shock. In recent years, the use of ECMO in China has also made great progress, but there are some problems in the construction of ECMO centers and ECMO-related technologies. Read More

View Article and Full-Text PDF

The role of temporary mechanical circulatory support as a bridge to advanced heart failure therapies or recovery.

Curr Opin Cardiol 2022 Jun 28. Epub 2022 Jun 28.

Division of Cardiology, Columbia University Irving Medical Center, New York, New York, USA.

Purpose Of Review: Temporary mechanical circulatory support (tMCS) has become central in the treatment of refractory cardiogenic shock and can be used to bridge patients to durable MCS, heart transplant or recovery. This review will discuss contemporary data regarding bridging strategies utilizing tMCS.

Recent Findings: There has been significant growth in tMCS use recently, driven by increased familiarity with tMCS devices, and increased experience with both implantation and management. Read More

View Article and Full-Text PDF

The use of veno-arterial extracorporeal membrane oxygenation in the octogenarian population: A single-center experience.

Perfusion 2022 Jun 29:2676591221111506. Epub 2022 Jun 29.

Department of Advanced Cardiopulmonary Therapies and Transplantation, 12340The University of Texas Health Science Center at Houston, Houston, TX, USA.

Introduction: Advanced age is a known risk factor for poor outcomes after veno-arterial extracorporeal membrane oxygenation (V-A ECMO) for cardiac support. The use of ECMO support in patients over the age of 80 is controversial, and sometimes its use is contraindicated. We aimed to assess the use of ECMO in octogenarian patients to determine survival and complication rates. Read More

View Article and Full-Text PDF

Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation.

Crit Care 2022 06 28;26(1):190. Epub 2022 Jun 28.

Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wuerzburg, Oberduerrbacherstr. 6, 97080, Würzburg, Germany.

Background: Severe COVID-19 induced acute respiratory distress syndrome (ARDS) often requires extracorporeal membrane oxygenation (ECMO). Recent German health insurance data revealed low ICU survival rates. Patient characteristics and experience of the ECMO center may determine intensive care unit (ICU) survival. Read More

View Article and Full-Text PDF

Palliative Care Impact on COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation.

J Pain Symptom Manage 2022 Jun 25. Epub 2022 Jun 25.

Department of Management, Policy, and Community Health (MPACH), University of Texas School of Public Health; UTHealth Consortium on Aging; and VA Center of Innovations, DeBakey VA Medical Center, Houston, Texas USA.

Context: Patients with severe respiratory failure from COVID-19 refractory to conventional therapies may be treated with extracorporeal membrane oxygenation (ECMO). ECMO requirement is associated with high mortality and prolonged hospital course. ECMO is a high-resource intervention with significant burdens placed on caregivers and families with limited data on the integration of palliative care consultation (PCC). Read More

View Article and Full-Text PDF

Heparin-free after 3000 IU heparin loaded in veno-venous ECMO supported acute respiratory failure patients with hemorrhage risk: a novel anti-coagulation strategy.

Thromb J 2022 Jun 27;20(1):36. Epub 2022 Jun 27.

Department of Surgery ICU, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.

Background: The anti-coagulation protocol of patients with hemorrhage risk primary disease who need extracorporeal membrane oxygenation (ECMO) supported is controversial. This study evaluated the feasibility of a new anti-coagulation strategy, that is heparin-free after 3000 IU heparin loaded in veno-venous ECMO (VV ECMO) supported acute respiratory failure patients with hemorrhage risk.

Methods: A retrospective study was performed in a series of hemorrhage risk patients supported with VV ECMO at the First Affiliated Hospital of Zhengzhou University, between June 2012 to Sept 2020. Read More

View Article and Full-Text PDF